FIELD: immunology.
SUBSTANCE: there are presented applications of pharmaceutical compositions containing an effective amount of an antibody or its antigen-binding fragment which specifically binds interleukin-4 receptor (IL-4R).
EFFECT: present invention can find further application in therapy of chronic rhinosinusitis with nasal polyposis (CRSwNP).
32 cl, 24 dwg, 56 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR TREATING NASAL POLYPOSIS BY ADMINISTERING IL-4R ANTAGONIST | 2014 |
|
RU2674680C2 |
| METHODS OF TREATING OR PREVENTING ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2713406C2 |
| METHODS OF TREATING OR PREVENTING ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2020 |
|
RU2832774C2 |
| METHODS FOR TREATMENT OR PREVENTION OF ASTHMA BY ADMINISTRATION OF IL-4R ANTAGONIST | 2018 |
|
RU2793745C2 |
| METHODS OF TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-33 ANTAGONIST | 2020 |
|
RU2838119C2 |
| METHOD OF TREATING SKIN INFECTION BY ADMINISTERING ANTAGONIST IL-4R | 2015 |
|
RU2704999C2 |
| METHODS FOR INCREASING VACCINE EFFICIENCY BY INJECTING IL-4R ANTAGONIST | 2017 |
|
RU2753869C2 |
| METHODS OF TREATING ATOPIC DERMATITIS BY ADMINISTERING IL-4R ANTAGONIST | 2020 |
|
RU2828020C2 |
| METHODS FOR TREATMENT OR PREVENTION OF ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2013 |
|
RU2690675C2 |
| METHODS FOR PREVENTING OR TREATING ALLERGIES BY INTRODUCING AN IL-4R ANTAGONIST | 2017 |
|
RU2777328C2 |
